Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy

A population-based and case-controlled study of children and adolescents with narcolepsy: health-related quality of life, adaptive behavior and parental stress

(2019) Attila Szakács et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis

(2019) Katie Zomorodi et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Antidepressants for the treatment of narcolepsy: A prospective study of 148 patients in northern China

(2019) Lang Jin et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Factors Influencing Time to Diagnosis in Childhood Narcolepsy Type 1

(2019) Sarah Levy et al.   JOURNAL OF CHILD NEUROLOGY

A randomized study of solriamfetol for excessive sleepiness in narcolepsy

(2019) Michael J. Thorpy et al.   ANNALS OF NEUROLOGY

Pitolisant and intravenous cocaine self-administration in mice

(2019) Benjamin Huyts et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor

(2018) Michelle G. Baladi et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Multiple Treatment Comparison in Narcolepsy: a Network Meta-analysis

(2018) Philippe Lehert et al.   SLEEP

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy

(2018) Andrea Romigi et al.   Drug Design Development and Therapy

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3): A Randomized Controlled Trial

(2018) Paula K. Schweitzer et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Solriamfetol for the Treatment of Excessive Sleepiness in OSA

(2018) Patrick J. Strollo et al.   CHEST

A Phase I, Randomized, Crossover, Open-Label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food

(2018) Katie Zomorodi et al.   CLINICAL THERAPEUTICS

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor

(2018) Lawrence P Carter et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Orexin supplementation in narcolepsy treatment: A review

(2018) Eugenie Nepovimova et al.   MEDICINAL RESEARCH REVIEWS

The neurobiological basis of narcolepsy

(2018) Carrie E. Mahoney et al.   NATURE REVIEWS NEUROSCIENCE

Investigational therapies for the treatment of narcolepsy

(2017) Stefano de Biase et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy

(2017) Kiran Maski et al.   Journal of Clinical Sleep Medicine

Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial

(2017) Zoltan Szakacs et al.   LANCET NEUROLOGY

Dopaminergic Regulation of Sleep and Cataplexy in a Murine Model of Narcolepsy

(2017) Christian R. Burgess et al.   SLEEP

The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality

(2016) Chad Ruoff et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study

(2016) Chad Ruoff et al.   SLEEP

Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy

(2016) Jed Black et al.   SLEEP MEDICINE

Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study

(2016) Chad Ruoff et al.   SLEEP

Narcolepsy

(2015) Thomas E. Scammell   NEW ENGLAND JOURNAL OF MEDICINE

Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy

(2015) Richard K. Bogan et al.   SLEEP MEDICINE

Catechol-O-methyltransferase, dopamine, and sleep-wake regulation

(2015) Yves Dauvilliers et al.   SLEEP MEDICINE REVIEWS

The Burden of Narcolepsy Disease (BOND) study: health-care utilization and cost findings

(2014) Jed Black et al.   SLEEP MEDICINE

Residual sleepiness in sleep apnea patients treated by continuous positive airway pressure

(2013) Merce Gasa et al.   JOURNAL OF SLEEP RESEARCH

Modafinil as a Catecholaminergic Agent: Empirical Evidence and Unanswered Questions

(2013) Jonathan Wisor   Frontiers in Neurology

A Practical Guide to the Therapy of Narcolepsy and Hypersomnia Syndromes

(2012) Emmanuel J. M. Mignot   Neurotherapeutics

Pharmacokinetics of armodafinil and modafinil after single and multiple doses in patients with excessive sleepiness associated with treated obstructive sleep apnea: A randomized, open-label, crossover study

(2010) Mona Darwish et al.   CLINICAL THERAPEUTICS

Differential Effects of GABAB Receptor Subtypes,  -Hydroxybutyric Acid, and Baclofen on EEG Activity and Sleep Regulation

(2010) J. Vienne et al.   JOURNAL OF NEUROSCIENCE

Sleep disorders and accidental risk in a large group of regular registered highway drivers

(2010) Pierre Philip et al.   SLEEP MEDICINE

Armodafinil in the treatment of sleep/wake disorders

(2010) Jonathan Schwartz   Neuropsychiatric Disease and Treatment

How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion

(2009) Sibah Hasan et al.   NEUROPSYCHOPHARMACOLOGY